Please login to the form below

Not currently logged in
Email:
Password:

disenchantment

This page shows the latest disenchantment news and features for those working in and with pharma, biotech and healthcare.

The death of deference

The death of deference

One social factor,  important to the rise of the life science industry, that is rarely discussed was disenchantment. ... In my work, I discern a 21st century parallel to disenchantment, namely the 'death of deference'.

Latest news

  • History rhymes: modern globalisation trends mirror the past History rhymes: modern globalisation trends mirror the past

    It's not hard to see parallels with our connected world. And at the same time, the sociologist Weber recorded 'The Age of Disenchantment' as the public began to move its

  • Building a good defence

    Disenchantment discontinuers are different. Research shows that, barring a major safety event or government directive, the main reason for disenchantment is simply misinformation; confusion, conflicting messages or incomplete understanding.

  • NHS news in brief

    ìIt would seem that disenchantment with the government translates into scepticism about the service.î.

  • Question Master

    Like all potentially great ideas, an excess of enthusiasm might be followed by disenchantment if patient-reported health questionnaires became the fashion and practice of all Trusts over night.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics